The Europe Prefilled Syringes Market would witness market growth of 10.0% CAGR during the forecast period (2022-2028).
Innovative improvements like buried needles are crucial in the context of self-injection devices in minimizing such injuries, leading to enhanced patient convenience. Prefilled syringes offer security without the increased expense, so their use is anticipated to rise in the coming years. In the coming years, auto-injector use is predicted to increase because to the devices' rising popularity and benefits including patient convenience and low contamination. For example, Owen Mumford Pharmaceutical Services announced its cutting-edge Aidaptus auto-injector platform in July 2021, after the full completion of development.
The two-step, spring-powered Aidaptus auto-injector, which accommodates all 2.25 mL and 1 mL prefilled glass syringes within the same base device, is anticipated to fuel market expansion in the coming years. Over the following years, it is anticipated that the usage of prefilled syringes would increase. Prefilled syringes have several benefits for the pharmaceutical industry, including reducing drug waste, lengthening the life of the product, and boosting market share. For health professionals, prefilled syringes are considered as an effective, dependable and convenient way for drug delivery.
Due to aspects like healthcare professionals' strong preference for prefilled injectable devices to reduce needle-related injuries, the regional market is expanding. Major market companies including SCHOTT group, Haselmeier AG, Stevanato Group, Gerresheimer AG, and Owen Mumford Ltd. are also present in the region. Over time, several businesses have increased their local presence. Due to this circumstance, the market has become more competitive in the region, making it challenging for new competitors to enter.
The Germany market dominated the Europe Prefilled Syringes Market by Country in 2021; thereby, achieving a market value of $921.4 million by 2028. The UK market is estimated to witness a CAGR of 9% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 10.8% during (2022 - 2028).
Based on Application, the market is segmented into Diabetes, Anaphylaxis, Rheumatoid Arthritis, and Others. Based on Therapeutics, the market is segmented into Large Molecules and Small Molecules. Based on Material, the market is segmented into Glass-based and Plastic-based. Based on Design, the market is segmented into Single-chamber, Dual-chamber, and Customized. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Prefilled Syringes Market will Hit $11.9 Billion by 2028, at a CAGR of 10.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Medtronic PLC, Nipro Corporation, Terumo Corporation, Vetter Pharma, West Pharmaceutical Services, Inc.
By Application
By Therapeutics
By Material
By Design
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 